Showing posts with label AmerisourceBergen. Show all posts
Showing posts with label AmerisourceBergen. Show all posts

Friday, November 9, 2018

AmerisourceBergen's compounding site still on ice despite beefed-up oversight - BioPharma Dive

Updated June 13, 2026

AmerisourceBergen does not own PharMEDium anymore because the drug compounding business was permanently shut down in 2020.

---  the original post follows below  ---

Read the full article:

AmerisourceBergen's compounding site still on ice despite beefed-up oversight - BioPharma Dive

"PharMEDium, a drug compounder and subsidiary of AmerisourceBergen, received a series of Form 483s over the last year as regulators observed issues at several of its manufacturing plants. Some of the more common issues included failing to have procedures that adequately protect against contamination or ensure quality control."

Return Home:  The Designated Representative and Exemptee Blog

---------------

Root Cause Analysis and Deviation Investigation Report Writing - An online self-study FDA cGMP training
Root Cause Analysis and Deviation Investigation Report Writing - An online self-study FDA cGMP training course

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Tuesday, October 2, 2018

AmerisourceBergen to pay $625M in drug distribution settlement - Modern Healthcare

Read the full article:  Modern Healthcare - AmerisourceBergen to pay $625M in drug distribution settlement

"In order to avoid the Food and Drug Administration's regulatory oversight, AmerisourceBergen did not register Medical Initiatives as a repackager or manufacturer with the agency, records show. Instead, the group portrayed Medical Initiatives as a state-regulated pharmacy, exploiting an exemption to the FDA registration requirement that is reserved for legitimate pharmacies, not for manufacturers or repackagers, authorities said."

Return Home:  The Designated Representative and Exemptee Blog

-------------------------------------

California Designated Representative Training Courses - accepted by the California State Board of Pharmacy
California Designated Representative Training Courses - accepted by the California State Board of Pharmacy


- - -


For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Thursday, May 1, 2014

Cardinal Health Profit Falls 8.7% - Wall Street Journal - WSJ.com

Cardinal Health Profit Falls 8.7% - Wall Street Journal - WSJ.com:

"Cardinal Health Inc. said its fiscal third-quarter earnings fell 8.7% as the drug wholesaler’s results were hurt by the expiration of its contract with Walgreen Co.

Cardinal Health was dealt a blow last year when Walgreen and European drug giant Alliance Boots GmbH agreed to get their branded and generic pharmaceutical products from rival AmerisourceBergen Corp.

Drug wholesalers have been forming ventures and collaborations with other health-care related companies in an effort to increase their bargaining power with pharmaceutical companies and expand internationally."

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Custom Search

From SkillsPlus International Inc.